항콕시듐제 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 수의학 증가, 동물에서 콕시듐증의 유병률 증가, 합성 약물의 사용 증가, 사료 첨가제 수요 증가, 가축 생산 증가로 인한 것입니다. 동향으로는 신흥의 콕시듐증주에 의한 수요의 급증, 자연적이고 대체적인 치료법으로의 전환, 기술 혁신을 촉진하는 규제당국의 감시 강화, 항생제 미사용 닭고기 제품에 대한 소멸 비용자의 선호도 증가, 약물 전달 기술의 진보, 예방 건강 관리 대책에 대한 주목 증가, 수산 양식 및 동반 동물 분야에서의 용도 확대 등을 들 수 있습니다.
육류 단백질에 대한 수요 증가는 향후 몇 년 동안 항콕시듐제물 시장의 성장을 가속할 것으로 예상됩니다. 대규모 수요 증가는 인구 증가, 가처분 소득 증가, 도시화, 단백질이 풍부한 식품에 대한 식생활 기호의 변화 등의 요인에 의해 초래되고 있습니다. 농가는 지속가능하고 효율적인 방식으로 증가하는 육류 단백질 수요를 충족시킬 수 있습니다. 2020-2022년 기준기간에서 2032년에 걸쳐 2% 증가할 전망인 반면 2022년 FAO 식육가격 지수는 수출 공급 감소로 10% 상승했습니다.
가금류의 급증은 향후 수년간 항콕시듐제 시장의 발전을 촉진할 전망입니다. 세계 무역의 확대에 기인합니다. 항콕시듐제물은 일반적으로 가금류를 콕시듐증으로부터 보호하기위한 선제 조치로서 가금의 초기 및 가장 영향을받는 성장 단계에서 사료 또는 물을 통해 투여됩니다. Economic Research Service가 보고한 바와 같이, 2022년 양계 부문의 총 매출은 769억 달러로 급증했고, 전년 대비 67% 증가한 현저한 성장을 보였습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 항콕시듐제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 항콕시듐제 시장 : 성장률 분석
- 세계의 항콕시듐제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 항콕시듐제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 항콕시듐제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 항콕시듐제 시장 : 약품 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 이온 포어
- 항생제
- 술폰아미드
- 화학 유도체
- 기타 약물 클래스
- 세계의 항콕시듐제 시장 : 약물 작용에 의한 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 콕시듐 억제
- 콕시듐 구제성
- 세계의 항콕시듐제 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 가금
- 돼지
- 물고기
- 소
- 반려동물
- 세계의 항콕시듐제 시장 : 유통채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 동물병원
- 소매 약국
- 기타 유통 채널
- 세계의 항콕시듐제 시장 :이온 포어별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 모넨신
- 라살로시드
- 살리노마이신
- 세계의 항콕시듐제 시장 : 항생제유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 타이로신
- 린코마이신
- 바시트라신
- 세계의 항콕시듐제 시장 : 설폰아미드유형별 하위 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 설파지메톡신
- 설파퀴녹살린
- 세계의 항콕시듐제 시장 : 화학 유도체별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 지쿠라즈릴
- 클로피돌
- 세계의 항콕시듐제 시장, 기타 약물 클래스 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 안프로리움
- 로베니딘
제7장 지역별, 국가별 분석
- 세계의 항콕시듐제 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 항콕시듐제 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 항콕시듐제 시장 : 경쟁 구도
- 항콕시듐제 시장 : 기업 프로파일
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Boehringer Ingelheim GmbH
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Intas Pharmaceuticals Ltd.
- Ceva Sante Animale SA
- Virbac SA
- Phibro Animal Health Corporation
- Vetoquinol SA
- Alpharma BVBA
- Kepro BV
- Kemin Industries Inc.
- Tianjin Ringpu Bio-Technology Co. Ltd.
- Hester Biosciences Limited
- Huvepharma AD
- Biovet SA
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 항콕시듐제 시장 2029 : 새로운 기회를 제공하는 국가
- 항콕시듐제 시장 2029 : 새로운 기회를 제공하는 부문
- 항콕시듐제 시장 2029 : 성장 전략
제36장 부록
SHW
Anticoccidial drugs constitute a category of medications employed in the prevention and treatment of coccidiosis, an intestinal parasitic ailment induced by protozoa from the genus Eimeria. These medications function by impeding diverse stages of the coccidia life cycle, thereby managing the infection and averting the consequential intestinal harm and associated symptoms. Widely utilized in veterinary practice, especially in poultry, these drugs contribute to bolstering health and productivity by addressing this prevalent and economically impactful condition.
The primary categories of anticoccidial drugs encompass ionophores, antibiotics, sulphonamides, chemical derivatives, and others. Ionophores, for instance, intervene in the proliferation and propagation of coccidia parasites by modulating ion movement across cellular membranes. These drugs exhibit varied actions, serving both coccidiostatic and coccidiocidal purposes across diverse applications such as poultry, swine, fish, cattle, and companion animals. They are distributed through various channels, including veterinary hospitals, retail pharmacies, among others.
The anticoccidial drugs market research report is one of a series of new reports from The Business Research Company that provides anticoccidial drugs market statistics, including anticoccidial drugs industry global market size, regional shares, competitors with a anticoccidial drugs market share, detailed anticoccidial drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anticoccidial drugs industry. This anticoccidial drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.
The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.
The increasing demand for meat proteins is expected to drive the growth of the anticoccidial drug market in the coming years. Meat proteins, which are naturally found in animal flesh, consist of various essential amino acids that play a crucial role in bodily functions. This rising demand for meat proteins is driven by factors such as population growth, higher disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are critical in modern livestock farming, as they help maintain animal health and productivity, allowing farmers to meet the growing demand for meat proteins in a sustainable and efficient manner. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development (OECD) and the Food and Agriculture Organization (FAO) noted that while global average per capita meat demand is expected to rise by 2% from the 2020-2022 base period to 2032, the FAO meat price index increased by 10% in 2022 due to lower export supplies. As a result, the growing demand for meat proteins is fueling the expansion of the anticoccidial drug market.
The upsurge in poultry farming is poised to drive the advancement of the anticoccidial drug market in the coming years. Poultry farming involves the rearing of domesticated avian species such as chickens, turkeys, ducks, and geese for the production of meat, eggs, and feathers. This increase in poultry farming is attributed to a growing demand for protein, enhancements in farming methodologies, and the expansion of global trade. Anticoccidial drugs are commonly administered to poultry either through feed or water as a preemptive measure to shield the birds from coccidiosis during their initial and most susceptible growth stages. For instance, as reported by the USDA Economic Research Service in June 2023, total sales in the poultry sector soared to $76.9 billion in 2022, marking a notable 67% surge from the preceding year. Hence, the surge in poultry farming acts as a catalyst for the burgeoning growth of the anticoccidial drug market.
Leading companies in the anticoccidial drugs market are focusing on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, reduce resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound used to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For example, in March 2023, Zoetis, a US-based animal health company, introduced Avi-Deccox, a reformulated synthetic coccidiostat designed to control coccidiosis in broiler chickens. This product targets the pathogens Eimeria acervulina and Eimeria tenella, which cause significant economic losses in poultry farming. Featuring decoquinate as its active ingredient, similar to its predecessor, Deccox, Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by utilizing a different mode of action, offering a more effective short-term knockdown effect.
Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc, Bayer AG, Novartis AG, Eli Lilly and Company Ltd, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Sante Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc, Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd
North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anticoccidial drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The anticoccidial drugs market consist of sales of monensin, semduramicin, lasalocid, decoquinate, salinomycin, amprolium, clopidol, and sulfachloropyrazine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anticoccidial Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anticoccidial drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anticoccidial drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anticoccidial drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Ionophore; Antibiotic; Sulphonamides; Chemical Derivative; Other Drug Classes
- 2) By Drug Action: Coccidiostatic; Coccidiocidal
- 3) By Application: Poultry; Swine; Fish; Cattle; Companion Animals
- 4) By Distribution Channel: Veterinary Hospitals; Retail Pharmacy; Other Distribution Channels
- Subsegments:
- 1) By Ionophore: Monensin; Lasalocid; Salinomycin
- 2) By Antibiotic: Tylosin; Lincomycin; Bacitracin
- 3) By Sulphonamides: Sulfadimethoxine; Sulfaquinoxaline
- 4) By Chemical Derivative: Diclazuril; Clopidol
- 5) By Other Drug Classes: Amprolium; Robenidine
- Companies Mentioned: Johnson & Johnson; Merck and Co. Inc; Bayer AG; Novartis AG; Eli Lilly and Company Ltd
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anticoccidial Drugs Market Characteristics
3. Anticoccidial Drugs Market Trends And Strategies
4. Anticoccidial Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Anticoccidial Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Anticoccidial Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Anticoccidial Drugs Market Growth Rate Analysis
- 5.4. Global Anticoccidial Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Anticoccidial Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Anticoccidial Drugs Total Addressable Market (TAM)
6. Anticoccidial Drugs Market Segmentation
- 6.1. Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Ionophore
- Antibiotic
- Sulphonamides
- Chemical Derivative
- Other Drug Classes
- 6.2. Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Coccidiostatic
- Coccidiocidal
- 6.3. Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Poultry
- Swine
- Fish
- Cattle
- Companion Animals
- 6.4. Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Veterinary Hospitals
- Retail Pharmacy
- Other Distribution Channels
- 6.5. Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monensin
- Lasalocid
- Salinomycin
- 6.6. Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tylosin
- Lincomycin
- Bacitracin
- 6.7. Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfadimethoxine
- Sulfaquinoxaline
- 6.8. Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diclazuril
- Clopidol
- 6.9. Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amprolium
- Robenidine
7. Anticoccidial Drugs Market Regional And Country Analysis
- 7.1. Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anticoccidial Drugs Market
- 8.1. Asia-Pacific Anticoccidial Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anticoccidial Drugs Market
- 9.1. China Anticoccidial Drugs Market Overview
- 9.2. China Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anticoccidial Drugs Market
- 10.1. India Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anticoccidial Drugs Market
- 11.1. Japan Anticoccidial Drugs Market Overview
- 11.2. Japan Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anticoccidial Drugs Market
- 12.1. Australia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anticoccidial Drugs Market
- 13.1. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anticoccidial Drugs Market
- 14.1. South Korea Anticoccidial Drugs Market Overview
- 14.2. South Korea Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anticoccidial Drugs Market
- 15.1. Western Europe Anticoccidial Drugs Market Overview
- 15.2. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anticoccidial Drugs Market
- 16.1. UK Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anticoccidial Drugs Market
- 17.1. Germany Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anticoccidial Drugs Market
- 18.1. France Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anticoccidial Drugs Market
- 19.1. Italy Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anticoccidial Drugs Market
- 20.1. Spain Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anticoccidial Drugs Market
- 21.1. Eastern Europe Anticoccidial Drugs Market Overview
- 21.2. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anticoccidial Drugs Market
- 22.1. Russia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anticoccidial Drugs Market
- 23.1. North America Anticoccidial Drugs Market Overview
- 23.2. North America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anticoccidial Drugs Market
- 24.1. USA Anticoccidial Drugs Market Overview
- 24.2. USA Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anticoccidial Drugs Market
- 25.1. Canada Anticoccidial Drugs Market Overview
- 25.2. Canada Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anticoccidial Drugs Market
- 26.1. South America Anticoccidial Drugs Market Overview
- 26.2. South America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anticoccidial Drugs Market
- 27.1. Brazil Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anticoccidial Drugs Market
- 28.1. Middle East Anticoccidial Drugs Market Overview
- 28.2. Middle East Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anticoccidial Drugs Market
- 29.1. Africa Anticoccidial Drugs Market Overview
- 29.2. Africa Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anticoccidial Drugs Market Competitive Landscape And Company Profiles
- 30.1. Anticoccidial Drugs Market Competitive Landscape
- 30.2. Anticoccidial Drugs Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis
31. Anticoccidial Drugs Market Other Major And Innovative Companies
- 31.1. Boehringer Ingelheim GmbH
- 31.2. Zoetis Inc.
- 31.3. Elanco Animal Health Incorporated
- 31.4. Intas Pharmaceuticals Ltd.
- 31.5. Ceva Sante Animale S.A.
- 31.6. Virbac S.A.
- 31.7. Phibro Animal Health Corporation
- 31.8. Vetoquinol SA
- 31.9. Alpharma BVBA
- 31.10. Kepro B.V.
- 31.11. Kemin Industries Inc.
- 31.12. Tianjin Ringpu Bio-Technology Co. Ltd.
- 31.13. Hester Biosciences Limited
- 31.14. Huvepharma AD
- 31.15. Biovet S.A.
32. Global Anticoccidial Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anticoccidial Drugs Market
34. Recent Developments In The Anticoccidial Drugs Market
35. Anticoccidial Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Anticoccidial Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Anticoccidial Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Anticoccidial Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
